The hospital-acquired infection control market size has grown steadily in recent years. It will grow from $33.01 billion in 2023 to $34.35 billion in 2024 at a compound annual growth rate (CAGR) of 4.1%. The increase observed in the historical period can be ascribed to increasing antibiotic resistance, growing awareness, stringent regulations, the globalization of infectious diseases, and patient safety initiatives.
The hospital-acquired infection control market size is expected to see steady growth in the next few years. It will grow to $41.37 billion in 2028 at a compound annual growth rate (CAGR) of 4.8%. The expansion anticipated in the forecast period can be linked to the rise of multidrug-resistant pathogens, pandemic preparedness, increased surveillance and monitoring, antimicrobial stewardship programs, and international collaboration. Major trends projected for the forecast period encompass the adoption of real-time location systems (RTLS), integration of artificial intelligence (AI) for surveillance, a shift towards single-use and disposable devices, emphasis on staff training and education, and increased utilization of UV-C and other disinfection technologies.
The hospital-acquired infection control market is anticipated to experience growth driven by the surge in COVID-19 cases. COVID-19, caused by the SARS-CoV-2 virus, has led to an increased demand for infection control products and services, emphasizing personal hygiene and the production of medical supplies. As of August 8, 2022, global COVID-19 cases reached 581.6 million, according to the World Health Organization, underscoring the market's expansion due to the ongoing pandemic.
The hospital-acquired infection control market is poised for growth, driven by the anticipated increase in healthcare expenditures. Healthcare expenditures encompass the total spending on healthcare-related services, products, and activities over a specified period. With a rise in healthcare spending, hospitals and healthcare facilities are expected to allocate additional resources for the adoption of advanced infection prevention technologies, including innovative solutions such as advanced disinfection systems and smart monitoring devices. For example, in May 2023, the UK's Office for National Statistics reported a 9.4% increase in healthcare spending, totaling $367.25 billion (£280.7 billion) in 2021. The substantial growth in healthcare expenditure is expected to propel the hospital-acquired infection control market.
Premier companies are at the forefront of the hospital-acquired infection control market, emphasizing technological advancements. These leading players are dedicated to creating innovative technological solutions to take the lead in the market. For example, in November 2021, scientists from the University of Pittsburgh School of Medicine and Carnegie Mellon University employed machine learning technology coupled with whole genome sequencing to rapidly identify infectious disease outbreaks in hospitals. This method detects significant outbreaks that might otherwise escape routine infection prevention monitoring.
Premier companies in the hospital-acquired infection control market are innovating by developing profitable products, such as digital platforms. In this context, a digital platform refers to an integrated and technology-driven solution designed to manage, monitor, and enhance infection prevention and control measures within healthcare facilities. For instance, Nanosonics, an Australia-based healthcare technology provider, launched AuditPro in June 2021. AuditPro is an advanced infection prevention platform tailored for medical settings, particularly focusing on ultrasound procedures. It incorporates a mobile scanning device, a user-friendly app for decision support, real-time risk alerts, and information-packed dashboards. Organizations can choose between the AuditPro Digital Logbook or the Workflow Compliance Management Solution, both seamlessly integrating with the trophon2 device for comprehensive infection prevention.
In June of 2021, Steris Corporation, a US-based medical equipment company specializing in sterilization and surgical products, acquired Cantel Medical for an undisclosed sum. This acquisition is expected to enable Steris to expand its product and service offerings and enhance its global reach. Cantel Medical, a US-based manufacturer of infection prevention products, was the target of this acquisition.
Major companies operating in the hospital-acquired infection control market report are Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton Dickinson and Company, Reckitt Benckiser Group plc., Ecolab Inc., Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Sterigenics International LLC, Nanosonics Limited, Advanced Sterilization Products Services Inc., Steelco S.P.A, Schülke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd., Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., Zep Inc.
North America was the largest region in the hospital-acquired infection control market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hospital-acquired infection control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The primary types of products in hospital-acquired infection control encompass sterilizers, disinfectors, endoscope reprocessors, microbial testing instruments, reagents, consumables, disinfectants, infection prevention and surveillance software, and others. Sterilizers, machines designed to thoroughly cleanse and eliminate bacteria, are employed to kill germs on surfaces or in fluids, preventing disease transmission. Various technologies, including phenotypic and genotypic methods, address diseases such as hospital-acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections, and others. Applications range from disease testing to drug-resistance testing, with end users including hospitals, ICUs, ambulatory surgical and diagnostic centers, nursing homes, maternity centers, and others.
The hospital-acquired infection control market research report is one of a series of new reports that provides hospital-acquired infection control market statistics, including hospital-acquired infection control industry global market size, regional shares, competitors with a hospital-acquired infection control market share, detailed hospital-acquired infection control market segments, market trends and opportunities, and any further data you may need to thrive in the hospital-acquired infection control industry. This hospital-acquired infection control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hospital-acquired infection control market includes revenues earned by entities by heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment, other sterilization equipment, contract sterilization services, sterilization consumables and accessories, disinfectants, and disinfectors equipment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The hospital-acquired infection control market size is expected to see steady growth in the next few years. It will grow to $41.37 billion in 2028 at a compound annual growth rate (CAGR) of 4.8%. The expansion anticipated in the forecast period can be linked to the rise of multidrug-resistant pathogens, pandemic preparedness, increased surveillance and monitoring, antimicrobial stewardship programs, and international collaboration. Major trends projected for the forecast period encompass the adoption of real-time location systems (RTLS), integration of artificial intelligence (AI) for surveillance, a shift towards single-use and disposable devices, emphasis on staff training and education, and increased utilization of UV-C and other disinfection technologies.
The hospital-acquired infection control market is anticipated to experience growth driven by the surge in COVID-19 cases. COVID-19, caused by the SARS-CoV-2 virus, has led to an increased demand for infection control products and services, emphasizing personal hygiene and the production of medical supplies. As of August 8, 2022, global COVID-19 cases reached 581.6 million, according to the World Health Organization, underscoring the market's expansion due to the ongoing pandemic.
The hospital-acquired infection control market is poised for growth, driven by the anticipated increase in healthcare expenditures. Healthcare expenditures encompass the total spending on healthcare-related services, products, and activities over a specified period. With a rise in healthcare spending, hospitals and healthcare facilities are expected to allocate additional resources for the adoption of advanced infection prevention technologies, including innovative solutions such as advanced disinfection systems and smart monitoring devices. For example, in May 2023, the UK's Office for National Statistics reported a 9.4% increase in healthcare spending, totaling $367.25 billion (£280.7 billion) in 2021. The substantial growth in healthcare expenditure is expected to propel the hospital-acquired infection control market.
Premier companies are at the forefront of the hospital-acquired infection control market, emphasizing technological advancements. These leading players are dedicated to creating innovative technological solutions to take the lead in the market. For example, in November 2021, scientists from the University of Pittsburgh School of Medicine and Carnegie Mellon University employed machine learning technology coupled with whole genome sequencing to rapidly identify infectious disease outbreaks in hospitals. This method detects significant outbreaks that might otherwise escape routine infection prevention monitoring.
Premier companies in the hospital-acquired infection control market are innovating by developing profitable products, such as digital platforms. In this context, a digital platform refers to an integrated and technology-driven solution designed to manage, monitor, and enhance infection prevention and control measures within healthcare facilities. For instance, Nanosonics, an Australia-based healthcare technology provider, launched AuditPro in June 2021. AuditPro is an advanced infection prevention platform tailored for medical settings, particularly focusing on ultrasound procedures. It incorporates a mobile scanning device, a user-friendly app for decision support, real-time risk alerts, and information-packed dashboards. Organizations can choose between the AuditPro Digital Logbook or the Workflow Compliance Management Solution, both seamlessly integrating with the trophon2 device for comprehensive infection prevention.
In June of 2021, Steris Corporation, a US-based medical equipment company specializing in sterilization and surgical products, acquired Cantel Medical for an undisclosed sum. This acquisition is expected to enable Steris to expand its product and service offerings and enhance its global reach. Cantel Medical, a US-based manufacturer of infection prevention products, was the target of this acquisition.
Major companies operating in the hospital-acquired infection control market report are Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton Dickinson and Company, Reckitt Benckiser Group plc., Ecolab Inc., Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Sterigenics International LLC, Nanosonics Limited, Advanced Sterilization Products Services Inc., Steelco S.P.A, Schülke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd., Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., Zep Inc.
North America was the largest region in the hospital-acquired infection control market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hospital-acquired infection control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The primary types of products in hospital-acquired infection control encompass sterilizers, disinfectors, endoscope reprocessors, microbial testing instruments, reagents, consumables, disinfectants, infection prevention and surveillance software, and others. Sterilizers, machines designed to thoroughly cleanse and eliminate bacteria, are employed to kill germs on surfaces or in fluids, preventing disease transmission. Various technologies, including phenotypic and genotypic methods, address diseases such as hospital-acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections, and others. Applications range from disease testing to drug-resistance testing, with end users including hospitals, ICUs, ambulatory surgical and diagnostic centers, nursing homes, maternity centers, and others.
The hospital-acquired infection control market research report is one of a series of new reports that provides hospital-acquired infection control market statistics, including hospital-acquired infection control industry global market size, regional shares, competitors with a hospital-acquired infection control market share, detailed hospital-acquired infection control market segments, market trends and opportunities, and any further data you may need to thrive in the hospital-acquired infection control industry. This hospital-acquired infection control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hospital-acquired infection control market includes revenues earned by entities by heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment, other sterilization equipment, contract sterilization services, sterilization consumables and accessories, disinfectants, and disinfectors equipment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Hospital-Acquired Infection Control Market Characteristics3. Hospital-Acquired Infection Control Market Trends and Strategies32. Global Hospital-Acquired Infection Control Market Competitive Benchmarking33. Global Hospital-Acquired Infection Control Market Competitive Dashboard34. Key Mergers and Acquisitions in the Hospital-Acquired Infection Control Market
4. Hospital-Acquired Infection Control Market - Macro Economic Scenario
5. Global Hospital-Acquired Infection Control Market Size and Growth
6. Hospital-Acquired Infection Control Market Segmentation
7. Hospital-Acquired Infection Control Market Regional and Country Analysis
8. Asia-Pacific Hospital-Acquired Infection Control Market
9. China Hospital-Acquired Infection Control Market
10. India Hospital-Acquired Infection Control Market
11. Japan Hospital-Acquired Infection Control Market
12. Australia Hospital-Acquired Infection Control Market
13. Indonesia Hospital-Acquired Infection Control Market
14. South Korea Hospital-Acquired Infection Control Market
15. Western Europe Hospital-Acquired Infection Control Market
16. UK Hospital-Acquired Infection Control Market
17. Germany Hospital-Acquired Infection Control Market
18. France Hospital-Acquired Infection Control Market
19. Italy Hospital-Acquired Infection Control Market
20. Spain Hospital-Acquired Infection Control Market
21. Eastern Europe Hospital-Acquired Infection Control Market
22. Russia Hospital-Acquired Infection Control Market
23. North America Hospital-Acquired Infection Control Market
24. USA Hospital-Acquired Infection Control Market
25. Canada Hospital-Acquired Infection Control Market
26. South America Hospital-Acquired Infection Control Market
27. Brazil Hospital-Acquired Infection Control Market
28. Middle East Hospital-Acquired Infection Control Market
29. Africa Hospital-Acquired Infection Control Market
30. Hospital-Acquired Infection Control Market Competitive Landscape and Company Profiles
31. Hospital-Acquired Infection Control Market Other Major and Innovative Companies
35. Hospital-Acquired Infection Control Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Hospital-Acquired Infection Control Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on hospital-acquired infection control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
- Report will be updated with the latest data and delivered to you with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for hospital-acquired infection control? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Report Scope
Markets Covered:1) By Product: Sterilizers; Disinfectors; Endoscope Reprocessors; Microbial Testing Instruments; Consumables; Disinfectants; Infection Prevention and Surveillance Software; Other Products
2) By Technology: Phenotypic Methods; Genotypic Methods
3) By Diseases: Hospital Acquired Pneumonia; Bloodstream Infections; Surgical Site Infections; Gastrointestinal Infections; Urinary Tract Infection; Other Diseases
4) By Application: Disease Testing; Drug-Resistance Testing
5) By End-user: Hospitals; ICUs; Ambulatory Surgical; Diagnostic Centers; Nursing Homes; Maternity Centers; Other End-users
Key Companies Mentioned: Johnson and Johnson; P&G Professional; Honeywell International Inc.; MMM Group; 3M Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
Delivery Format: PDF, Word and Excel Data Dashboard
Companies Mentioned
- Johnson and Johnson
- P&G Professional
- Honeywell International Inc.
- MMM Group
- 3M Company
- Becton Dickinson and Company
- Reckitt Benckiser Group plc.
- Ecolab Inc
- Olympus Corporation
- Miele Group
- Biomerieux SA
- Getinge AB
- Halyard Health Inc.
- Ansell Limited
- Sotera Health LLC
- Contec Inc.
- Cantel Medical Corp.
- Belimed AG
- Sterigenics International LLC
- Nanosonics Limited
- Advanced Sterilization Products Services Inc
- Steelco S.P.A
- Schülke & Mayr GmbH
- Metrex Research LLC
- Tristel Solutions Ltd.
- Whiteley Corporation
- PDI Inc.
- Steris Healthcare PVT Ltd
- Matachana Group
- Pal International Ltd.
- Xttrium Laboratories Inc.
- Zep Inc.
Methodology
LOADING...
